Agentix Corp. (AGTX) income statement
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 0/30
$0.02+0.00 (0.00%)
Close on Oct 16, 2026Market cap $801.34KP/E –Yield –
Agentix Corp. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- 14.5%
Financial strength
- Current ratio
- 0.00
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?